Dr. Richard A. Larson describes what people with cancer should know about blood transfusions, including why a blood transfusion might be needed during cancer, the different types of transfusions, what to expect during a transfusion, and possible side effects.
2023 ASCO Annual Meeting Research Round Up: Advances in Treating Gynecologic Cancers, Multiple Myeloma, and Head and Neck Cancer
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting in ovarian cancer, uterine cancer, cervical cancer, multiple myeloma, and head and neck cancer.
2023 ASCO Annual Meeting Research Round Up: Progress in Treating Breast Cancer, Lymphoma, Multiple Myeloma, and Brain Tumors
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting in breast cancer, lymphoma, multiple myeloma, brain tumors, and von Hippel-Lindau syndrome.
Dr. Amar Kelkar and Dr. Vincent Ho discuss what people with cancer and their caregivers should know about recovery in the weeks and months after a bone marrow transplant, including what follow-up care will be needed, what symptoms may occur, and how daily life may change.
ASCO Annual Meeting 2023: Trastuzumab Deruxtecan Effectively Treats HER2-Expressing Tumors and CAR T-cell Therapy Helps Slow or Stop Multiple Myeloma
The ASCO Annual Meeting is being held June 2 to 6. Research highlights from the day include using trastuzumab deruxtecan to treat HER2-expressing tumors and using CAR T-cell therapy to slow or stop multiple myeloma.
Composer and multiple myeloma survivor Ed Hartman shares how having creative outlets like music and writing have helped him manage the mental and physical impacts of his cancer diagnosis and treatment.
2022 ASCO Annual Meeting Research Round Up: Advances in Treating Multiple Myeloma, Breast Cancer, and Cancer in People 60 and Older
In this podcast, members of the American Society of Clinical Oncology (ASCO) discuss new research presented at the 2022 ASCO Annual Meeting in multiple myeloma, breast cancer, and cancer in people age 60 or older.
2022 ASCO Annual Meeting: Advances in Treating Breast Cancer, Colorectal Cancer, Ewing Sarcoma, and Multiple Myeloma
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma.
Dr. William Dale discusses 5 key studies presented at the SIOG 2020 Annual Meeting Online that involve improvements in evaluating, caring for, and treating people with cancer who are 60 or older.
ASCO Annual Meeting 2019: Treatment Advances for Metastatic Prostate Cancer and Pancreatic Cancer, Multiple Myeloma Survival Factors, and Effects of the Affordable Care Act on Cancer Care
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include an effective medication for metastatic prostate cancer, targeted therapy that slows the growth of metastatic pancreatic cancer, how socioeconomic factors may affect survival for multiple myeloma, and how the ACA resulted in earlier treatment and improved equality in care.